F062 Making the Most of Health Information Technology: Tools for the Dermatology Practice
DESCRIPTION
Health information technology (IT) capabilities are rapidly evolving. This session will highlight advances in health IT that impact practice and physician workflows as well as the patient experience.
Topics to Be Covered:
1. Patient engagement: Present an overview of building an online presence and connecting with patients
2. Digital imaging and dermatopathology: Review the latest in digital imaging technology and dermatopathology
3. Augmented intelligence (AI): Explore the concept of agentic AI and its applications to dermatology practice
4. Ethics: Discuss ethical considerations as they apply to IT tools in dermatology practice
LEARNING OBJECTIVES
Identify recent advances in health IT as they relate to EHR capabilities, digital imaging, patient engagement, and support staff tools
Assess feasibility of applying health IT solutions to dermatology practices
Describe the barriers and challenges of integrating evolving health IT solutions into current practice
SCHEDULE
3:30 PM
Introduction
Milad Eshaq, MD, FAAD
3:40 PM
Beyond the Exam Room: How Digital Presence Shapes Patient Relationships
Angela Lamb, MD, FAAD
3:55 PM
Digital Imaging
Trilokraj Tejasvi, MD, MBBS
4:10 PM
Digital Dermatopathology
Ryan Walter Hick, MD, FAAD
4:25 PM
Agentic AI
Faranak Kamangar, MD, FAAD
4:40 PM
Ethical Considerations for IT Tools in a Dermatology Practice
Jane Margaret Grant-Kels, MD, FAAD
5:00 PM
Q&A
Justin Ko, MD, MBA, FAAD
DIRECTOR
Milad Eshaq, MD, FAAD
University of Michigan Medical School
CO-DIRECTOR
Justin Ko, MD, MBA, FAAD
SPEAKERS
Jane Margaret Grant-Kels, MD, FAAD
Ryan Walter Hick, MD, FAAD
Faranak Kamangar, MD, FAAD
Angela Lamb, MD, FAAD
Trilokraj Tejasvi, MD, MBBS
DISCLOSURES
Milad Eshaq, MD, FAAD
No financial relationships exist with ineligible companies.
Jane Margaret Grant-Kels, MD, FAAD
No financial relationships exist with ineligible companies.
Ryan Walter Hick, MD, FAAD
PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Justin Ko, MD, MBA, FAAD
AbbVie – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Enspectra Health – Consultant(Fees); Google Research – Investigator(Grants/Research Funding); Hims – Consultant(Fees); Orlucent – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees); Skin Analytics – Consultant(Fees);
Angela Lamb, MD, FAAD
AbbVie – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Botanix Pharmaceuticals – Speaker(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); RoC – Advisory Board(Honoraria);
Trilokraj Tejasvi, MD, MBBS
No financial relationships exist with ineligible companies.